Clinical Trials Logo

Clinical Trial Summary

Despite recreational cannabis now being legal in 23 states, where more than 100 million Americans reside, studies on the actual health effects are limited. This study is a randomized trial, where each participant will be instructed to consume or avoid cannabis on randomly assigned days during a 14-day monitoring period. The goal of this study is to answer the question: "Does cannabis use increase the frequency of 'early' and abnormal heart beats?" During the 14-day period, participants will wear an external heart monitor, a glucose monitor, and a fitness tracker to track heart rhythm, glucose levels, step counts, and sleep health. Participants will use a mobile app or a text messaging service for daily instructions/reminders on cannabis use, and short surveys. The investigators ask that participants smoke or vape cannabis at least once on days they are instructed to consume cannabis. Compelling evidence of heart and other health effects would be important to the clinical care of our patients.


Clinical Trial Description

This study is designed as a case-crossover randomized trial, where each participant will be instructed to consume or avoid inhaled cannabis on randomly assigned days during a 14-day monitoring period. Participants will be asked to smoke or vape cannabis at least once on days they are instructed to consume cannabis. Participants will also wear an external electrocardiographic (ECG) monitor, a continuous glucose monitor, and a fitness tracker for up to two weeks while utilizing a mobile application or text messaging service to receive daily instructions/reminders on cannabis use, and short surveys. The investigators will compare participant self-report of cannabis consumption, glucose monitoring, fitness levels, sleep health, and heart rhythm data in order to better understand the relationship between acute cannabis consumption and heart rhythm changes. A total of 100 participants will be enrolled at the UCSF study site. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06021613
Study type Interventional
Source University of California, San Francisco
Contact Gregory M Marcus, MD, MAS
Phone 415-476-5706
Email greg.marcus@ucsf.edu
Status Recruiting
Phase N/A
Start date January 18, 2023
Completion date November 2026

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05784051 - Prophylactic Frequent Premature Ventricular complexeS sUPPression on Left ventriculaR Function impairmEnt in aSymptomatic patientS Phase 4
Completed NCT03671759 - Coffee and Real-time Atrial and Ventricular Ectopy N/A
Completed NCT02279030 - Use of MIBG Scan Images in PVC Ablations
Active, not recruiting NCT02919618 - Phase I/II Study of EP-guided Noninvasive Cardiac Radioablation for Treatment of Ventricular Tachycardia Phase 1/Phase 2
Not yet recruiting NCT05158751 - Myocarditis Causing Premature Ventricular Contractions:Insights From the MAVERIC Registry
Terminated NCT01757067 - Early Elimination of Premature Ventricular Contractions in Heart Failure N/A
Not yet recruiting NCT06146556 - Concealed Myocardial Abnormalities by Cardiac Magnetic Resonance Imaging in Idiopathic VT